China Universal Asset Management Co., Ltd. Gilead Sciences, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 214,428 shares of GILD stock, worth $14.3 Million. This represents 2.03% of its overall portfolio holdings.
Number of Shares
214,428
Previous 214,428
-0.0%
Holding current value
$14.3 Million
Previous $15.7 Million
0.01%
% of portfolio
2.03%
Previous 2.0%
Shares
12 transactions
Others Institutions Holding GILD
# of Institutions
1,885Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.16 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$7.64 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$5.63 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.08 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$3.84 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $83.5B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...